| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $686K | +141.5% |
| R&D Expense | $3.8M | -37.5% |
| SG&A Expense | $4.5M | +23.5% |
| Operating Income | -$7.6M | +19.4% |
| Interest Expense | $168K | -33.4% |
| Pre-tax Income | -$11.3M | -5.5% |
| Income Tax | $17K | — |
| Net Income | -$11.3M | -5.6% |
| EPS (Basic) | -$1.83 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.8M | -48.6% |
| Current Assets | $2.5M | -38.7% |
| Total Assets | $5.1M | -28.6% |
| Current Liabilities | $1.6M | -27.9% |
| Total Liabilities | $2.2M | -77.4% |
| Stockholders' Equity | $2.9M | +108.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.4M | +11.8% |
| Capital Expenditures | $27K | -19.8% |
| Investing Cash Flow | -$318K | +5.5% |
| Financing Cash Flow | $6.0M | +44.7% |
| Free Cash Flow | -$7.4M | +11.9% |
| +85.6% |
| EPS (Diluted) | -$1.83 | +85.6% |